547 related articles for article (PubMed ID: 18430306)
1. The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma.
Mansfield LE
Allergy Asthma Proc; 2008; 29(2):103-8. PubMed ID: 18430306
[TBL] [Abstract][Full Text] [Related]
2. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.
Chung KF; Caramori G; Adcock IM
Eur J Clin Pharmacol; 2009 Sep; 65(9):853-71. PubMed ID: 19557399
[TBL] [Abstract][Full Text] [Related]
3. The use of inhaled formoterol in the treatment of asthma.
Berger WE
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
[TBL] [Abstract][Full Text] [Related]
4. Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta 2-agonists.
Miller-Larsson A; Selroos O
Curr Pharm Des; 2006; 12(25):3261-79. PubMed ID: 17020533
[TBL] [Abstract][Full Text] [Related]
5. Safety of long-acting β agonists for the treatment of asthma: clearing the air.
Rodrigo GJ; Castro-Rodríguez JA
Thorax; 2012 Apr; 67(4):342-9. PubMed ID: 21515554
[TBL] [Abstract][Full Text] [Related]
6. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular safety of long acting beta agonist-inhaled corticosteroid combination products in adult patients with asthma: a systematic review.
Iftikhar IH; Imtiaz M; Brett AS; Amrol DJ
Lung; 2014 Feb; 192(1):47-54. PubMed ID: 24153452
[TBL] [Abstract][Full Text] [Related]
8. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
[TBL] [Abstract][Full Text] [Related]
9. [Do fixed ICS/LABA-combinations have advantages in terms of patient-centered parameters?].
Buhl R
Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S381-5. PubMed ID: 19941241
[No Abstract] [Full Text] [Related]
10. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
Gibson PG; Powell H; Ducharme FM
J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
[TBL] [Abstract][Full Text] [Related]
11. Combination corticosteroid/β-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma?
Beasley R; Weatherall M; Shirtcliffe P; Hancox R; Reddel HK
J Allergy Clin Immunol; 2014 Jan; 133(1):39-41. PubMed ID: 24369798
[TBL] [Abstract][Full Text] [Related]
12. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
13. Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review.
Rodrigo GJ; Moral VP; Marcos LG; Castro-Rodriguez JA
Pulm Pharmacol Ther; 2009 Feb; 22(1):9-19. PubMed ID: 19026757
[TBL] [Abstract][Full Text] [Related]
14. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
Eltonsy S; Forget A; Beauchesne MF; Blais L
J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
[TBL] [Abstract][Full Text] [Related]
15. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
16. Is it safe to use long-acting beta-agonists in asthma and chronic obstructive pulmonary disease? Implications of recent trials and meta-analyses.
Sears MR
Pol Arch Med Wewn; 2008 Dec; 118(12):761-6. PubMed ID: 19202956
[TBL] [Abstract][Full Text] [Related]
17. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
Hanania NA
Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
[TBL] [Abstract][Full Text] [Related]
18. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma.
Bisgaard H; Le Roux P; Bjåmer D; Dymek A; Vermeulen JH; Hultquist C
Chest; 2006 Dec; 130(6):1733-43. PubMed ID: 17166990
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological strategies for self-management of asthma exacerbations.
Reddel HK; Barnes DJ;
Eur Respir J; 2006 Jul; 28(1):182-99. PubMed ID: 16816348
[TBL] [Abstract][Full Text] [Related]
20. Long-acting beta-agonists and their association with inhaled corticosteroids in COPD.
Fuso L; Mores N; Valente S; Malerba M; Montuschi P
Curr Med Chem; 2013; 20(12):1477-95. PubMed ID: 23409722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
